Q4 2020 Dare Bioscience Inc Earnings Call Transcript
Welcome to the conference call hosted by Daré Bioscience to review the company's financial results for the year ended December 31, 2020, and to provide a general business update. This call is being recorded. My name is Sara, and I will be your operator today.
With us today are Sabrina Martucci Johnson, Daré's President and Chief Executive Officer; John Fair, Daré's Chief Strategy Officer; and Lisa Walters-Hoffert, Daré's Chief Financial Officer.
Ms. Johnson, please proceed.
© -
Thank you. Good afternoon, and welcome to our 2020 financial results and business update call for Daré Bioscience. Our plan today is to review last year's financial results, discuss notable achievements since our last call in November and use the time to highlight developments and milestones anticipated for 2021.
Before I begin, I would like to remind you that today's discussion will include forward-looking statements within the meaning of
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |